文献速递炎症性肠病胃肠动力与功能性疾病

综述:肠-脑轴在炎症性肠病中的作用及其治疗意义

Review article: The role of the gut-brain axis in inflammatory bowel disease and its therapeutic implications.
PubMed 文献 · Aliment Pharmacol Ther · 2024-10-05

该叙述性综述检索MEDLINE、EMBASE、EMBASE Classic、PsychINFO和Cochrane中央对照试验注册库至2024年3月的文献,探讨肠-脑轴在炎症性肠病中的双向作用及靶向治疗潜力。心理幸福感与不良纵向疾病活动结局之间的双向关系及肠易激综合征型症状报告的高患病率提示肠-脑轴介导效应存在。靶向肠-脑相互作用的治疗包括脑-肠行为治疗、神经调节剂和饮食干预,似乎对部分患者是有用的辅助治疗。

要点

  • 炎症性肠病患者中心理疾病患病率高,肠易激综合征型症状报告常见。
  • 心理幸福感与纵向疾病活动结局存在双向关系,由肠-脑轴介导。
  • 脑-肠行为治疗、神经调节剂和饮食干预似乎对部分患者是有用的辅助治疗。

核心结论

  • 心理疾病在炎症性肠病患者中普遍存在。
  • 纵向疾病活动结局、肠易激综合征型症状报告与不良心理健康之间的关系通过肠-脑轴介导。
  • 应将对心理健康的主动管理整合到常规诊疗中。
  • 需要在合并常见精神障碍或报告肠易激综合征型症状的选定患者群体中开展进一步的肠-脑轴靶向治疗临床试验,以为未来的有效整合诊疗模式提供依据。

研究设计与样本

  • 叙述性综述,检索MEDLINE、EMBASE、EMBASE Classic、PsychINFO和Cochrane中央对照试验注册库至2024年3月发表的相关文章。

主要发现

  • 心理幸福感与不良纵向疾病活动结局之间的双向关系以及肠易激综合征型症状报告的高患病率,突显了炎症性肠病中肠-脑轴介导效应的存在。
  • 靶向肠-脑相互作用的治疗包括脑-肠行为治疗、神经调节剂和饮食干预,似乎对部分患者是有用的辅助治疗。

关键数值与推荐

  • 靶向肠-脑轴的治疗对减少肠易激综合征的症状负担有效。
  • 炎症性肠病中常见精神障碍和肠易激综合征型症状报告的患病率显著高于预期。

临床怎么用

  • 应将对心理健康的主动管理整合到常规诊疗中。
  • 脑-肠行为治疗、神经调节剂和饮食干预似乎可作为部分炎症性肠病患者的辅助治疗。
  • 需要在合并常见精神障碍或报告肠易激综合征型症状的选定患者中开展进一步的肠-脑轴靶向治疗临床试验。

局限性

  • 需要在合并常见精神障碍或报告肠易激综合征型症状的选定患者群体中开展进一步的肠-脑轴靶向治疗临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatments targeting the gut-brain axis (GBA) are effective at reducing symptom burden in irritable bowel syndrome (IBS). The prevalence of common mental disorders and IBS-type symptom reporting is significantly higher in inflammatory bowel disease (IBD) than would be expected, suggesting potential GBA effects in this setting. Manipulation of the GBA may offer novel treatment strategies in selected patients with IBD. We present a narrative review of the bi-directional effects of the GBA in IBD and explore the potential for GBA-targeted therapies in this setting. METHODS: We searched MEDLINE, EMBASE, EMBASE Classic, PsychINFO, and the Cochrane Central Register of Controlled Trials for relevant articles published by March 2024. RESULTS: The bi-directional relationship between psychological well-being and adverse longitudinal disease activity outcomes, and the high prevalence of IBS-type symptom reporting highlight the presence of GBA-mediated effects in IBD. Treatments targeting gut-brain interactions including brain-gut behavioural treatments, neuromodulators, and dietary interventions appear to be useful adjunctive treatments in a subset of patients. CONCLUSIONS: Psychological morbidity is prevalent in patients with IBD. The relationship between longitudinal disease activity outcomes, IBS-type symptom reporting, and poor psychological health is mediated via the GBA. Proactive management of psychological health should be integrated into routine care. Further clinical trials of GBA-targeted therapies, conducted in selected groups of patients with co-existent common mental disorders, or those who report IBS-type symptoms, are required to inform effective integrated models of care in the future.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Riggott C, Ford AC, Gracie DJ, et al. Review article: The role of the gut-brain axis in inflammatory bowel disease and its therapeutic implications. Aliment Pharmacol Ther. 2024. PMID: 39367676. doi:10.1111/apt.18192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。